| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Neoplasms | 21 | 2024 | 753 | 9.070 |
Why?
|
| Embolization, Therapeutic | 16 | 2024 | 263 | 8.720 |
Why?
|
| Carcinoma, Hepatocellular | 16 | 2024 | 396 | 8.260 |
Why?
|
| Vena Cava Filters | 14 | 2022 | 98 | 7.770 |
Why?
|
| Venous Thrombosis | 11 | 2024 | 252 | 5.410 |
Why?
|
| Radiography, Interventional | 14 | 2024 | 156 | 4.860 |
Why?
|
| Vena Cava, Inferior | 8 | 2022 | 144 | 4.260 |
Why?
|
| Bile Duct Neoplasms | 6 | 2024 | 90 | 4.150 |
Why?
|
| Yttrium Radioisotopes | 13 | 2024 | 58 | 3.810 |
Why?
|
| Device Removal | 9 | 2022 | 168 | 3.690 |
Why?
|
| Cholangiocarcinoma | 5 | 2024 | 76 | 3.470 |
Why?
|
| Pulmonary Embolism | 6 | 2024 | 229 | 3.080 |
Why?
|
| Radiology, Interventional | 7 | 2022 | 69 | 3.060 |
Why?
|
| Angiography | 9 | 2024 | 208 | 2.680 |
Why?
|
| Treatment Outcome | 38 | 2024 | 8218 | 2.650 |
Why?
|
| Thrombectomy | 8 | 2024 | 189 | 2.440 |
Why?
|
| Foreign-Body Migration | 4 | 2020 | 39 | 2.440 |
Why?
|
| Chemoembolization, Therapeutic | 4 | 2023 | 35 | 2.410 |
Why?
|
| Medicare | 6 | 2023 | 426 | 2.310 |
Why?
|
| Prosthesis Implantation | 4 | 2020 | 126 | 2.310 |
Why?
|
| Catheter Ablation | 4 | 2022 | 253 | 2.130 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 288 | 2.020 |
Why?
|
| Computed Tomography Angiography | 7 | 2022 | 153 | 1.950 |
Why?
|
| Radiopharmaceuticals | 4 | 2024 | 195 | 1.650 |
Why?
|
| Thrombolytic Therapy | 4 | 2023 | 238 | 1.610 |
Why?
|
| Osteoarthritis, Knee | 2 | 2024 | 66 | 1.600 |
Why?
|
| Humans | 78 | 2024 | 89613 | 1.540 |
Why?
|
| Retrospective Studies | 28 | 2024 | 9127 | 1.530 |
Why?
|
| Microspheres | 7 | 2024 | 108 | 1.350 |
Why?
|
| Brachytherapy | 2 | 2021 | 121 | 1.280 |
Why?
|
| Vascular Patency | 3 | 2024 | 129 | 1.260 |
Why?
|
| Venous Thromboembolism | 2 | 2021 | 159 | 1.260 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2018 | 606 | 1.210 |
Why?
|
| Gastrostomy | 2 | 2021 | 70 | 1.210 |
Why?
|
| Malpractice | 2 | 2019 | 57 | 1.200 |
Why?
|
| Prosthesis Failure | 2 | 2019 | 116 | 1.150 |
Why?
|
| Social Media | 2 | 2020 | 95 | 1.140 |
Why?
|
| Radiology | 2 | 2020 | 202 | 1.110 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2024 | 41 | 1.080 |
Why?
|
| Bile Ducts, Intrahepatic | 5 | 2023 | 72 | 1.050 |
Why?
|
| Catheterization | 3 | 2021 | 237 | 1.040 |
Why?
|
| Lower Extremity | 2 | 2023 | 88 | 1.030 |
Why?
|
| Liability, Legal | 3 | 2022 | 32 | 1.000 |
Why?
|
| Radiation Dosage | 3 | 2020 | 226 | 0.990 |
Why?
|
| Consensus | 2 | 2024 | 363 | 0.960 |
Why?
|
| Mesenteric Veins | 1 | 2024 | 34 | 0.950 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2024 | 63 | 0.920 |
Why?
|
| Hepatic Artery | 2 | 2024 | 84 | 0.920 |
Why?
|
| Portal Vein | 1 | 2024 | 121 | 0.920 |
Why?
|
| Recurrence | 2 | 2024 | 1143 | 0.880 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 476 | 0.870 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2024 | 237 | 0.870 |
Why?
|
| Hepatic Encephalopathy | 1 | 2023 | 39 | 0.850 |
Why?
|
| Liver Abscess | 1 | 2022 | 11 | 0.840 |
Why?
|
| Hepatectomy | 1 | 2024 | 172 | 0.840 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2024 | 2668 | 0.820 |
Why?
|
| Ischemia | 1 | 2024 | 252 | 0.800 |
Why?
|
| Aged | 20 | 2024 | 19158 | 0.780 |
Why?
|
| Acute Disease | 4 | 2024 | 842 | 0.770 |
Why?
|
| Fistula | 1 | 2021 | 42 | 0.740 |
Why?
|
| Brachiocephalic Veins | 1 | 2021 | 34 | 0.730 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2021 | 53 | 0.720 |
Why?
|
| Hospital Units | 1 | 2020 | 30 | 0.720 |
Why?
|
| Tumor Burden | 4 | 2024 | 305 | 0.720 |
Why?
|
| Middle Aged | 23 | 2024 | 26012 | 0.720 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.710 |
Why?
|
| Time Factors | 9 | 2024 | 5337 | 0.700 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 54 | 0.700 |
Why?
|
| Risk Factors | 13 | 2024 | 5517 | 0.700 |
Why?
|
| Surgical Instruments | 1 | 2020 | 57 | 0.690 |
Why?
|
| Vascular Diseases | 1 | 2021 | 118 | 0.690 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 80 | 0.690 |
Why?
|
| Hydrocephalus | 1 | 2021 | 105 | 0.690 |
Why?
|
| Societies, Medical | 2 | 2021 | 582 | 0.680 |
Why?
|
| Catheters | 3 | 2022 | 83 | 0.680 |
Why?
|
| Phlebography | 4 | 2024 | 68 | 0.670 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2017 | 72 | 0.660 |
Why?
|
| Wounds, Gunshot | 1 | 2021 | 99 | 0.660 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 114 | 0.650 |
Why?
|
| Thrombosis | 1 | 2022 | 301 | 0.650 |
Why?
|
| Kyphoplasty | 1 | 2019 | 7 | 0.650 |
Why?
|
| Radiologists | 1 | 2019 | 49 | 0.640 |
Why?
|
| United States | 10 | 2024 | 7050 | 0.640 |
Why?
|
| Fractures, Compression | 1 | 2019 | 17 | 0.640 |
Why?
|
| Aorta | 1 | 2020 | 289 | 0.630 |
Why?
|
| Specialization | 1 | 2019 | 70 | 0.620 |
Why?
|
| Appendicitis | 1 | 2019 | 65 | 0.620 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 6771 | 0.610 |
Why?
|
| Rectum | 1 | 2019 | 148 | 0.600 |
Why?
|
| Stents | 1 | 2021 | 409 | 0.600 |
Why?
|
| Spinal Fractures | 1 | 2019 | 81 | 0.600 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 103 | 0.600 |
Why?
|
| Radiation Injuries | 1 | 2019 | 162 | 0.590 |
Why?
|
| Hemorrhage | 1 | 2019 | 284 | 0.580 |
Why?
|
| Renal Dialysis | 2 | 2017 | 337 | 0.580 |
Why?
|
| Prosthesis Design | 4 | 2019 | 298 | 0.570 |
Why?
|
| Female | 25 | 2024 | 46401 | 0.570 |
Why?
|
| Radiosurgery | 1 | 2020 | 287 | 0.570 |
Why?
|
| Male | 22 | 2024 | 42488 | 0.560 |
Why?
|
| Catheters, Indwelling | 2 | 2014 | 114 | 0.550 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 360 | 0.550 |
Why?
|
| Physicians | 2 | 2022 | 691 | 0.530 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 208 | 0.530 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 1060 | 0.530 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 297 | 0.510 |
Why?
|
| Finger Phalanges | 1 | 2015 | 4 | 0.510 |
Why?
|
| Metacarpal Bones | 1 | 2015 | 12 | 0.500 |
Why?
|
| Anticoagulants | 3 | 2024 | 428 | 0.480 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 5 | 0.470 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2014 | 99 | 0.460 |
Why?
|
| Arteriovenous Fistula | 1 | 2014 | 53 | 0.460 |
Why?
|
| Sutures | 1 | 2014 | 57 | 0.460 |
Why?
|
| Salvage Therapy | 1 | 2014 | 231 | 0.440 |
Why?
|
| Young Adult | 7 | 2024 | 6368 | 0.440 |
Why?
|
| Equipment Design | 3 | 2024 | 420 | 0.430 |
Why?
|
| Suture Techniques | 1 | 2014 | 144 | 0.430 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 322 | 0.410 |
Why?
|
| Infusions, Intra-Arterial | 2 | 2024 | 36 | 0.410 |
Why?
|
| Microwaves | 2 | 2022 | 36 | 0.410 |
Why?
|
| Adult | 12 | 2024 | 26704 | 0.410 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 854 | 0.410 |
Why?
|
| Heart Ventricles | 1 | 2017 | 779 | 0.400 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 1097 | 0.390 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 1185 | 0.390 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 219 | 0.360 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2022 | 171 | 0.350 |
Why?
|
| Adolescent | 7 | 2021 | 9305 | 0.340 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2023 | 99 | 0.330 |
Why?
|
| Product Surveillance, Postmarketing | 2 | 2019 | 38 | 0.310 |
Why?
|
| Fluoroscopy | 3 | 2024 | 123 | 0.280 |
Why?
|
| United States Food and Drug Administration | 2 | 2017 | 135 | 0.270 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2024 | 19 | 0.240 |
Why?
|
| Pneumothorax | 2 | 2015 | 53 | 0.240 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 70 | 0.240 |
Why?
|
| Suction | 1 | 2024 | 37 | 0.240 |
Why?
|
| Transfusion Medicine | 1 | 2024 | 4 | 0.240 |
Why?
|
| Hypertrophy | 1 | 2024 | 67 | 0.230 |
Why?
|
| Liver Regeneration | 1 | 2024 | 36 | 0.230 |
Why?
|
| Biopsy | 2 | 2020 | 1183 | 0.230 |
Why?
|
| Radiometry | 1 | 2024 | 56 | 0.220 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 124 | 0.220 |
Why?
|
| Lasers, Excimer | 1 | 2022 | 5 | 0.210 |
Why?
|
| Fractures, Spontaneous | 1 | 2023 | 11 | 0.210 |
Why?
|
| Necrosis | 1 | 2023 | 210 | 0.210 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 223 | 0.210 |
Why?
|
| Arteries | 1 | 2023 | 179 | 0.200 |
Why?
|
| Capecitabine | 1 | 2022 | 93 | 0.200 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 46 | 0.200 |
Why?
|
| Perfusion | 1 | 2023 | 237 | 0.200 |
Why?
|
| Biomarkers | 2 | 2021 | 1768 | 0.200 |
Why?
|
| Transplants | 1 | 2022 | 41 | 0.200 |
Why?
|
| Iliac Vein | 1 | 2022 | 30 | 0.200 |
Why?
|
| Aneurysm | 1 | 2022 | 60 | 0.200 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 168 | 0.200 |
Why?
|
| Contraindications, Procedure | 1 | 2021 | 7 | 0.200 |
Why?
|
| Contraindications, Drug | 1 | 2021 | 4 | 0.200 |
Why?
|
| Sheep | 1 | 2022 | 251 | 0.200 |
Why?
|
| Fibrinolysis | 1 | 2022 | 37 | 0.190 |
Why?
|
| Postoperative Complications | 3 | 2017 | 2297 | 0.190 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 255 | 0.190 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 56 | 0.190 |
Why?
|
| Orthopedic Procedures | 1 | 2023 | 129 | 0.190 |
Why?
|
| Orthopedics | 1 | 2023 | 130 | 0.180 |
Why?
|
| Enteral Nutrition | 1 | 2021 | 105 | 0.180 |
Why?
|
| Pain | 1 | 2023 | 399 | 0.180 |
Why?
|
| Retreatment | 1 | 2021 | 107 | 0.180 |
Why?
|
| Liver Function Tests | 1 | 2020 | 92 | 0.180 |
Why?
|
| Postoperative Hemorrhage | 1 | 2021 | 46 | 0.180 |
Why?
|
| Cisplatin | 1 | 2022 | 598 | 0.180 |
Why?
|
| Research Design | 1 | 2024 | 589 | 0.180 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 98 | 0.180 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 59 | 0.180 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 16 | 0.180 |
Why?
|
| Workflow | 1 | 2020 | 81 | 0.170 |
Why?
|
| Hypotension | 1 | 2020 | 71 | 0.170 |
Why?
|
| Congresses as Topic | 1 | 2020 | 115 | 0.170 |
Why?
|
| Radiation Exposure | 1 | 2019 | 25 | 0.170 |
Why?
|
| Workload | 1 | 2020 | 129 | 0.170 |
Why?
|
| Disease Progression | 1 | 2024 | 1463 | 0.170 |
Why?
|
| Organs at Risk | 1 | 2019 | 40 | 0.160 |
Why?
|
| Mortality | 1 | 2020 | 149 | 0.160 |
Why?
|
| Appendectomy | 1 | 2019 | 38 | 0.160 |
Why?
|
| Radiography | 2 | 2019 | 806 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2021 | 714 | 0.160 |
Why?
|
| Anesthesia, General | 1 | 2019 | 116 | 0.160 |
Why?
|
| Glass | 1 | 2018 | 15 | 0.160 |
Why?
|
| Nephrectomy | 1 | 2021 | 291 | 0.160 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 60 | 0.160 |
Why?
|
| Contrast Media | 2 | 2024 | 1084 | 0.160 |
Why?
|
| Patient Care Team | 1 | 2021 | 283 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 136 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 260 | 0.150 |
Why?
|
| Hydrogels | 1 | 2019 | 87 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 1725 | 0.150 |
Why?
|
| Bone Marrow | 1 | 2020 | 443 | 0.150 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 434 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 265 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 836 | 0.150 |
Why?
|
| Jurisprudence | 1 | 2017 | 25 | 0.140 |
Why?
|
| Equipment Safety | 1 | 2017 | 33 | 0.140 |
Why?
|
| Chicago | 2 | 2019 | 1430 | 0.140 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 320 | 0.140 |
Why?
|
| Liver | 2 | 2024 | 1208 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2020 | 952 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2017 | 242 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2018 | 782 | 0.130 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 523 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1727 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3659 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 451 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2019 | 731 | 0.130 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.130 |
Why?
|
| Chest Tubes | 1 | 2015 | 24 | 0.130 |
Why?
|
| Kidney | 1 | 2021 | 1147 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 849 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1172 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 2003 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2017 | 348 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 238 | 0.120 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 23 | 0.120 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 37 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1851 | 0.120 |
Why?
|
| Thorax | 1 | 2014 | 77 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2021 | 3756 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 2503 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 114 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 358 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2020 | 2304 | 0.110 |
Why?
|
| Peritoneal Diseases | 1 | 2013 | 16 | 0.110 |
Why?
|
| Mesentery | 1 | 2013 | 45 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2014 | 184 | 0.100 |
Why?
|
| Choristoma | 1 | 2013 | 68 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2013 | 86 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 984 | 0.100 |
Why?
|
| Pancreas | 1 | 2013 | 249 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1605 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1050 | 0.090 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 763 | 0.070 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 231 | 0.060 |
Why?
|
| Editorial Policies | 1 | 2024 | 34 | 0.060 |
Why?
|
| Operative Time | 1 | 2024 | 145 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 322 | 0.060 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2024 | 43 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2024 | 170 | 0.050 |
Why?
|
| Splenic Artery | 1 | 2022 | 11 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 166 | 0.050 |
Why?
|
| Animals | 1 | 2022 | 27481 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 149 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 2364 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2022 | 150 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2022 | 149 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2022 | 193 | 0.050 |
Why?
|
| Incidence | 2 | 2015 | 1598 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2022 | 254 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2022 | 236 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2022 | 996 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1008 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 276 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2022 | 1172 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 848 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 1214 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1862 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 2878 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 4309 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 161 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3465 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 1887 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1073 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2016 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 952 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1877 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2763 | 0.020 |
Why?
|
| Lung | 1 | 2014 | 1273 | 0.020 |
Why?
|